Profusa Revenue and Competitors
Estimated Revenue & Valuation
- Profusa's estimated annual revenue is currently $8.3M per year.
- Profusa received $45.0M in venture funding in August 2018.
- Profusa's estimated revenue per employee is $125,500
- Profusa's total funding is $80.9M.
Employee Data
- Profusa has 66 Employees.
- Profusa grew their employee count by -3% last year.
Profusa's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Software and Data Science | Reveal Email/Phone |
2 | Head, Government Business | Reveal Email/Phone |
3 | Head Digital Health Business | Reveal Email/Phone |
4 | VP Medical Affairs & Clinical Development | Reveal Email/Phone |
5 | Director Quality | Reveal Email/Phone |
6 | Co-founder, President & Chief Scientific Officer | Reveal Email/Phone |
7 | Co-Founder, President & Chief Scientific Officer | Reveal Email/Phone |
8 | Director Software Engineering | Reveal Email/Phone |
9 | Director, Lumee O2 Product Management | Reveal Email/Phone |
10 | Product Manager | Reveal Email/Phone |
Profusa Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is Profusa?
Profusa's mission is to make our body's chemistry easily accessible to improve health and wellness. We are dedicated to becoming a leader in the development of real-time biosensors that provide unprecedented insights into our overall health status. We are leading the development of a new generation of biointegrated sensors that empowers the individual with the ability to monitor their unique body chemistry in unprecedented ways to transform the management of personal health and disease. Our technology enables the development of bioengineered sensors that become one with the body to detect and continuously transmit actionable, medical-grade data for personal and medical use. Profusa's first clinical offering, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. It may be used in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds (diabetic ulcers, pressure sores) that do not heal properly; and reconstructive surgery. Any questions Please visit profusa.com or email us at info@profusa.com
keywords:Biotechnology,Healthcare,Medical Devices,Medical Diagnostics$80.9M
Total Funding
66
Number of Employees
$8.3M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Profusa News
Profusa compra el hotel Arco de San Juan de Murcia. La compañía de desarrollos inmobiliarios del Grupo Fuertes realizará una remodelación y...
Quiere impulsar el desarrollo turístico de la Región de Murcia. La compañía de desarrollos inmobiliarios realizará una remodelación y tiene...
Profusa (Grupo Fuertes) adquiere el Hotel Arco de San Juan de 4 estrellas para impulsar el desarrollo turístico de la Región de Murcia.
SOUTH SAN FRANCISCO, Calif., Aug. 8, 2019 /PRNewswire/ -- Profusa, an empowered health company that is pioneering the next generation ...
Prior to joining Profusa, Icke led the Digital Health Business Unit at Becton Dickinson (BD), where he focused on consumer-centric digital ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $24M | 66 | -4% | $1.3B |
#2 | $5.1M | 66 | 10% | $316M |
#3 | $9.3M | 69 | 3% | N/A |
#4 | $17.6M | 70 | 6% | N/A |
#5 | $15M | 72 | 0% | N/A |
Profusa Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2015-12-17 | $13.2M | B | 3E Bioventures | Article |
2018-08-15 | $45.0M | C | VMS Investment Group | Article |